L

Lexicon Pharmaceuticals

D

LXRX

USD

0.08

(6.639%)

Market Closed

127,435.00

Volume

-0.85

EPS

-

Div Yield

-1.647436

P/E

464,517,599.08

Market Cap

Today

6.6390%

1 Week

-34.439%

1 Month

-23.512%

6 Months

-27.809%

12 Months

2.800%

Year To Date

-16.013%

All Time

0%

Related Instruments

Title:
Lexicon Pharmaceuticals

Sector:

Healthcare

Industry:

Biotechnology

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Do you need help or have a question?